Publication | Closed Access

Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese–diabetic mice

ObesityMetabolic SyndromeHealth SciencesBiochemistrySkeletal MuscleMedicineDiabetesPhysiologyObesity-induced Metabolic DisordersMetabolic RegulationMetabolic SignalingPharmacologyMetabolic HealthOxidative StressGlycosidic Flavonoid